Литература. 1.
Bella J.N., Palmieri V., Liu J.E. et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN)
Study // Hypertension. 2001. V. 38. № 3. P. 424–428.
2.
De Simone G., Greco R., Mureddu G. et al. Relation of left ventricular diastolic properties to systolic function in arterial hypertension // Circulation. 2000. V. 101. № 2. P. 152–157.
3.
De Simone G.; Devereux R.B., Koren M.J. et al. Midwall left ventricular mechanics. An indepen dent predictor of cardiovascular risk in arterial hypertension // Circulation. 1996. V. 93. № 2. P.
259–265.
4.
Weisman H.F., Bush D.E., Mannisi J.A., Bulkley B.H. Global cardiac remodeling after acute myocardial infarction: a study in the rat model // J. Am. Coll. Cardiol. 1985. V.
5.
№ 6. P. 1355–1362. 5. Rumberger J.A., Behrenbeck T., Breen J.R. et al. Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans // J. Am. Coll. Cardiol. 1993. V. 21. № 3. P. 673–682.
6.
Grundy S.M., Brewer B.H. Jr., Cleeman J.I. еt al. Definition of metabolic syndrome: Report of the
National Heart, Lung, and Blood Institute / American Heart Association conference on scientific issues related to definition // Circulation. 2004. V. 109. № 3. P. 433–438.
7.
Chinali M., de Simone G., Roman M.J. et al. Impact of obesity on cardiac geometry and func tion in a population of adolescents: the Strong Heart Study // J. Am. Coll. Cardiol. 2006. V. 47. № 11.
P. 2267–2273.
8.
Aijaz B., Ammar K.A., LopezJimenez F. et al. Abnormal cardiac structure and function in the metabolic syndrome: a populationbased study // Mayo Clin. Proc. 2008. V. 83. № 12. P. 1350–
1357.
9.
Muiesan M.L., Lupia M., Salvetti M. et al. Left ven tricular structural and functional characteristics in Cushing’s syndrome // J. Am. Coll. Cardiol. 2003. V. 41. № 12. P. 2275–2279.
10.
Zoccali C., Mallamaci F., Benedetto F.A. et al. Urotensin II and cardiomyopathy in endstage renal disease // Hypertension. 2008. V. 51. № 2. P. 326–333.
11.
Biederman R.W., Doyle M., Young A.A. et al. Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy //
Hypertension. 2008. V. 52. № 2. P. 279–286.
12.
Greenberg B., Quinones M.A., Koilpillai C. et al. Effects of longterm enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy // Circulation. 1995. V. 91. № 10. P. 2573–2581.
13.
Vandsburger M.H., French B.A., Helm P.A. et al. Multiparameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated betaadrenergic functional response in neuronal nitric oxide synthase knockout mice // Eur. Heart
J. 2007. V. 28. № 22. P. 2792–2798.
14.
Myerson S.G., Montgomery H.E., World M.J., Pennell D.J. Left ventricular mass: reliability of
Mmode and 2dimensional echocardiographic formulas // Hypertension. 2002. V. 40. № 5. P. 673–
678.
15.
Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle // J. Clin. Invest. 1975. V. 56. № 1. P. 56–64.
16.
Mannaerts H.F., van der Heide J.A., Kamp O. et al. Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography // Eur.
Heart J. 2004. V. 25. № 8. P. 680–687.
17.
Ganau A., Devereux R.B., Roman M.J. et al. Patterns of left ventricular hypertrophy and geo metric remodeling in essential hypertension // J. Am. Coll. Cardiol. 1992. V. 19. № 7. Р. 1550–
1558.
18.
Конради А.О., Жукова А.В., Винник Т.А. Структурно функциональные параметры миокарда у больных гипертонической
болезнью в зависимости от массы тела, типа